2022-08-31 13:28 pm
hPSC-based Regenerative Medicine by Innovative Technology Completely Overcoming Tumorigenicity
Platform technology with high through put design and development of tumorigenic
cell-targeting lentiviral vector (TC-LV), and producing master cells